Followers

0
0
9
9
.
7
7
9
9
0
0
,
1
1
4.90 (0.45%)

As on 21 Oct, 2025 | 14:56

Open Trading A/c
Day Range
1,094.00
1,101.40
LH
52 Week Range
572.00
1,104.30
LH
Volume
* i
Bid / Ask
87,428.00
0.00 / 0.00

Fortis Healthcare Announcements

HSBC Securities and Capital Markets (India) Private Limited, HDFC Bank Limited, Citigroup Global Markets India Private Limited and Deutsche Equities India Private Limited, ("Joint managers...

17 Oct, 2025 | 03:56pm • Source: BSE

The relevant disclosure is attached.

17 Oct, 2025 | 12:10pm • Source: BSE

In terms of Regulations 30 of SEBI (LODR) Regulations 2015, this is to inform you that the company is dispatching the postal ballot notice to...

16 Oct, 2025 | 04:22pm • Source: BSE

Newspaper Publication of recommendation of committee of Independent Directors on open offer to the shareholders of the company.

16 Oct, 2025 | 12:40pm • Source: BSE

The relevant disclosure is attached.

15 Oct, 2025 | 05:21pm • Source: BSE

HSBC Securities and Capital Markets (India) Private Limited, HDFC Bank Limited Investment Banking Group, Citigroup Global Markets India Private Limited and Deutsche Equities India Private...

09 Oct, 2025 | 05:37pm • Source: BSE

Please find enclosed certificates under Regulation 74(5) of SEBI (DP) Regulation, 2018

07 Oct, 2025 | 05:57pm • Source: BSE

The relevant disclosure is attached.

03 Oct, 2025 | 06:27pm • Source: BSE

The relevant disclosure is attached

30 Sep, 2025 | 06:02pm • Source: BSE

The relevant disclosure is attached.

26 Sep, 2025 | 12:44pm • Source: BSE

Please find attached the details of Investor Meetings with the Management Team of Fortis Healthcare Limited (''FHL''),

17 Sep, 2025 | 06:21pm • Source: BSE

Please find attached the details of Investor Meetings with the Management Team of Fortis Healthcare Limited ('FHL'),

17 Sep, 2025 | 06:17pm • Source: BSE

Publication of Special Window for re-lodgement of transfer requests of physical shares.

11 Sep, 2025 | 06:52pm • Source: BSE

Change in composition of Board pursuant to Appointment of Dr. Keith and resignation of Mr. Tomo Nagahiro effective from September 09, 2025 (close of business...

09 Sep, 2025 | 05:17pm • Source: BSE

The Relevant Disclosure with respect to Update on September 1, 2025 on Execution of Sub-Lease Agreement with R.R. Lifesciences Pvt. Ltd. is attached.

05 Sep, 2025 | 12:33pm • Source: BSE